Seeking Alpha
10 Aug 2026, 00:08 UTC · 2h ago
Trulieve Cannabis: First NYSE-Listed Cannabis Stock Is A Buy
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Seeking Alpha
10 Aug 2026, 00:08 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
The reclassification of medical marijuana to Schedule III will remove the 280E tax burden for Trulieve. — Eliminating a major tax burden directly increases net income and free cash flow, significantly boosting valuation.
+0.90Trulieve is the first U.S. cannabis operator to uplist to the NYSE. — Uplisting improves liquidity and allows institutional investors who are restricted from OTC markets to buy the stock.
+0.60Trulieve reported a profitable Q1 2026 with $42 million in free cash flow. — Proven profitability and positive cash flow reduce the risk profile and demonstrate operational sustainability.
+0.40The company has initiated a $50 million share repurchase program. — Buybacks signal management confidence and provide a floor for the stock price by reducing share supply.
Continue reading
6 related stories
Top 2 movers · tap to explore
Which stocks this story touches
The company is uplisting to the NYSE, executing share repurchases, reporting positive cash flow, and benefiting from the removal of the 280E tax burden.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
MarketBeat
1h ago
